Elliott Winton on the Changing Landscape of MPN Treatment

BY ELLIOTT WINTON, M.D.

Elliott Winton, M.D., researcher, physician and 2016 MPN Hero, discusses some of the drastic changes that happened over the past decade or so in the world of MPNs.

PUBLISHED: JANUARY 11, 2017

Elliott Winton, M.D., researcher, physician and 2016 MPN Hero, discusses some of the drastic changes that happened over the past decade or so in the world of MPNs.

Monumental change began about 11 years ago with the discovery of the JAK mutation, which led to new agents, future studies and more reliable diagnostic measures. Also, more studies are looking at the prognosis of patients diagnosed with MPNs, so that physicians can be more informed in discussing potential outcomes and treatment options with their patients.

Be the first to discuss this article on CURE's forum. >>

Talk about this article with other patients, caregivers, and advocates in the Myelodysplastic syndrome CURE discussion group.

CURE wants to hear from you! We are inviting you to Share Your Story with the readers of CURE. Submit your personal experience with cancer by visiting Share Your Story

Not yet receiving CURE in your mailbox? Sign up to receive CURE Magazine by visiting GetCureNow.com